Following FDA approval of Imaavy, we explore promising biotech candidates in development for myasthenia gravis.

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...

The European Union has launched the Choose Europe for Science initiative and pledged €500 million in funding to attract US ...

Find out if gene therapy has also find its way into skin diseases. With two approvals in the last 2 years, is it the start of ...

Discover seven lung cancer companies advancing promising candidates through the clinic, from viral immunotherapies to ...

Obesity has nearly tripled since 1975, becoming an ever-growing health threat. In 2016, it was estimated that more than 1.9 billion adults in the world were overweight, with more than 650 million of ...

First, let’s take a look at the private biotech investments in March 2025, breaking them down by value, location, funding type, and therapeutic subsector. In March 2025, drug discovery company ...

Gene therapy represents a transformative approach in modern medicine, with the potential to address and cure a wide array of genetic disorders. By introducing, modifying, or repairing genetic material ...